• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Trupanion Inc.

    2/10/23 4:36:07 PM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email
    SC 13G 1 d9943858_13g.htm

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

    (Rule 13d-102)

     

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (Amendment No.)

     

     

    TRUPANION, INC.
    (Name of Issuer)
     
     
    Common Stock
    (Title of Class of Securities)
     
     
    898202106
    (CUSIP Number)
     
     
    December 31, 2022
    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [x] Rule 13d-1(b)

    [_] Rule 13d-1(c)

    [_] Rule 13d-1(d)

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

    CUSIP No. 898202106    
         
    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Flossbach von Storch AG  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)  [_]
        (b)  [_]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Germany  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      0  
         
    6. SHARED VOTING POWER  
         
      2,880,000  
         
    7. SOLE DISPOSITIVE POWER  
         
      0  
         
    8. SHARED DISPOSITIVE POWER  
         
      2,880,000  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      2,880,000  
         
    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (SEE INSTRUCTIONS)

    [_]
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      7.0%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      IA, HC  
             

     

     
     

     

    CUSIP No. 898202106    
         
    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Flossbach von Storch Invest S.A.  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)  [_]
        (b)  [_]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Luxembourg  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      0  
         
    6. SHARED VOTING POWER  
         
      2,880,000  
         
    7. SOLE DISPOSITIVE POWER  
         
      0  
         
    8. SHARED DISPOSITIVE POWER  
         
      2,880,000  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
      2,880,000  
         
    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (SEE INSTRUCTIONS)

    [_]
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      7.0%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      IA  
             
     
     

     

     

    CUSIP No. 898202106  

     

    Item 1. (a). Name of Issuer:
         
        TRUPANION, INC.
         
      (b). Address of issuer's principal executive offices:
         
       

    6100 Fourth Avenue South, Suite 400

    Seattle, WA 98108

         
    Item 2. (a)-(c). Name Principal Business Address, and Citizenship of Person Filing:
         
       

    Flossbach von Storch AG

    Ottoplatz 1

    50679 Cologne

    Germany

         
       

    Flossbach von Storch Invest S.A.

    2, rue Jean Monnet

    L-2180

    Luxembourg

         
    Item 2. (d) Title of class of securities:
         
        Common Stock
         
    Item 2. (e). CUSIP No.:
         
        898202106
         

     

    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
           
      (a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
           
      (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
           
      (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act.
           
      (d) [_] Investment company registered under Section 8 of the Investment Company Act.
           
      (e) [x] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
           
      (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
           
      (g) [x] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
           

      (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
           
      (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
           
      (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

     

     
     

     

    Item 4. Ownership.
       
      Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
           
      (a) Amount beneficially owned:  
           
        Flossbach von Storch AG 2,880,000 shares
        Flossbach von Storch Invest S.A. 2,880,000 shares
           
           
      (b) Percent of class:  
           
        Flossbach von Storch AG 7.0%
        Flossbach von Storch Invest S.A. 7.0%
           
           
      (c) Number of shares as to which such person has:  
           
        (i) Sole power to vote or to direct the vote  
           
        Flossbach von Storch AG 0 shares
        Flossbach von Storch Invest S.A. 0 shares
           
           
        (ii) Shared power to vote or to direct the vote  
           
        Flossbach von Storch AG 2,880,000 shares
        Flossbach von Storch Invest S.A. 2,880,000 shares
           
           
        (iii) Sole power to dispose or to direct the disposition of  
           
        Flossbach von Storch AG 0 shares
        Flossbach von Storch Invest S.A. 0 shares
           
           
        (iv) Shared power to dispose or to direct the disposition of  
           
        Flossbach von Storch AG 2,880,000 shares
        Flossbach von Storch Invest S.A. 2,880,000 shares
           

     

     
     

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [ ].
       
      N/A
       
    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
       
      If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
       
      The securities reported in this Schedule 13G are held within advisory and discretionary portfolio management accounts of clients of the reporting persons. None of these clients own more than five percent of the Issuer’s Common Stock.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
       
      See Exhibit B attached hereto.
       
    Item 8. Identification  and  Classification  of Members of the Group.
       
      If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
       
      N/A
       
    Item 9. Notice of Dissolution of Group.
       
      Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
       
      N/A
       
    Item 10. Certifications.
       

     

      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
     
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

      February 10, 2023
      (Date)
       
       
      Flossbach von Storch AG (1)
       
      By: /s/ Dirk von Velsen
         
       
      Flossbach von Storch Invest S.A. (1)
       
      By: /s/ Christian Schlosser
         
       
      By: /s/ Markus Müller
       

     

     

    (1) The Reporting Persons disclaim beneficial ownership except to the extent of their pecuniary interest therein.

     

     
     

     

    EXHIBIT A

     

    AGREEMENT

     

     

    The undersigned agree that this Schedule 13G dated February 10, 2023 relating to the Common Stock of TRUPANION, INC. shall be filed on behalf of the undersigned.

       
      Flossbach von Storch AG
       
      By: /s/ Dirk von Velsen
         
       
      Flossbach von Storch Invest S.A.
       
       
      By: /s/ Christian Schlosser
         
       
      By: /s/ Markus Müller
         
       

     

     

     

     
     

     

    Exhibit B

     

    Flossbach von Storch Invest S.A. is the relevant entity for which Flossbach von Storch AG may be considered a parent holding company.

     

    Get the next $TRUP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    12/8/2021$126.00 → $183.00Overweight
    Piper Sandler
    More analyst ratings

    $TRUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Trupanion Inc.

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      11/8/24 10:46:38 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      4/5/24 4:09:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

      SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

      2/12/24 11:02:49 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    SEC Filings

    See more
    • SEC Form 10-Q filed by Trupanion Inc.

      10-Q - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 5:20:35 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 4:02:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by Trupanion Inc.

      DEFA14A - TRUPANION, INC. (0001371285) (Filer)

      5/1/25 6:05:54 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Trupanion upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

      1/23/25 7:55:01 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • William Blair initiated coverage on Trupanion

      William Blair initiated coverage of Trupanion with a rating of Outperform

      7/19/24 7:44:19 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion upgraded by BofA Securities with a new price target

      BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously

      5/16/24 7:37:42 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    See more
    • Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

      Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

      8/14/24 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

      SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

      5/2/24 4:04:29 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Appoints Richard Enthoven, Global Entrepreneur and Founder of Hollard Insurance Company Australia, as Independent Board Director

      A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta

      11/7/23 8:30:00 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Tooth Margaret sold $133,373 worth of shares (4,000 units at $33.34) and exercised 4,000 shares at a strike of $8.93 (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      4/23/25 4:19:30 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • CEO Tooth Margaret exercised 4,000 shares at a strike of $8.93 and sold $148,700 worth of shares (4,000 units at $37.17) (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/24/25 6:27:50 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Chief Administration Officer Mcgibney Brenna sold $164,926 worth of shares (5,000 units at $32.99), decreasing direct ownership by 57% to 3,738 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      3/11/25 4:20:06 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar

      SEATTLE, May 05, 2025 (GLOBE NEWSWIRE) -- Trupanion (NASDAQ:TRUP), the leading provider of medical insurance for dogs and cats, will host an upcoming webinar focused on the evolving state of bird flu (H5N1) and its impact on pets, pet parents, and the veterinary community. The complimentary one-hour RACE®-Approved CE webinar "Bird Flu: What We Know Now" will be available on-demand on petpublichealth.org/h5n1-update/ on Thursday, May 8th, at 11:00 AM PT / 2:00 PM ET. Hosted by Trupanion's Chief Veterinary/Product Officer, Dr. Steve Weinrauch, BVMS, MRCVS, the webinar features a panel of leading animal health experts, including: Gail Golab, PhD, DVM, MANZCVS (Animal Welfare), DACAW: Assoc

      5/5/25 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Publishes 2024 Annual Letter to Shareholders

      SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2024 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the hig

      4/30/25 5:15:00 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4) (Amendment)

      4/A - TRUPANION, INC. (0001371285) (Issuer)

      5/15/24 7:27:19 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4)

      4 - TRUPANION, INC. (0001371285) (Issuer)

      5/9/24 6:40:58 PM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Financials

    Live finance-specific insights

    See more
    • Trupanion Reports First Quarter 2025 Results

      SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

      5/1/25 4:05:07 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion, Inc. Announces First Quarter 2025 Earnings Release and Conference Call

      SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first quarter after the market closes on Thursday, May 1, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can acce

      4/17/25 4:30:00 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion Reports Fourth Quarter & Full Year 2024 Results

      SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. "2024 was a milestone year for Trupanion. Strong execution drove 20% subscription revenue growth, the doubling of our subscription margin in Q4 from its quarterly low in 2023, and a record $39 million in free cash flow," said Margi Tooth, Chief Executive Officer and President of Trupanion. "As we look to 2025, our focus remains on sustainable, measured growth while enhancing the member experience and improving retention." Fourth Quarter 2024 Financial and

      2/19/25 4:05:00 PM ET
      $TRUP
      Medical Specialities
      Health Care